|
| Press Releases |
|
 |
|
| Friday, May 18, 2018 |
|
|
Novotech称，联邦预算研发税收扶持使澳大利亚在高质量临床试验方面具有全球竞争力 |
| 亚太地区首席技术官对特恩布尔政府的联邦预算决定表示赞赏。该决定将临床试验活动排除在400万美元的现金退款限制或最大封顶限额之外。 more info >> |
|
|
Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials |
| Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds. more info >> |
|
| Friday, June 23, 2017 |
|
|
Novotech signs Central Lab Services Agreement with Sonic Clinical Trials |
| Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of international healthcare company, Sonic Healthcare. more info >> |
|
| Thursday, April 20, 2017 |
|
|
諾泰與韓國領先醫療中心（峨山醫療中心）簽署諒解備忘錄 |
| 亞太地區專家合同研究組織諾泰今日宣布，其已經與韓國最大的醫療機構——峨山醫療中心（AMC）的臨床研究中心簽署了諒解備忘錄（MOU）。該諒解備忘錄正式確定了諾泰與國際領先醫療中心及其主要研究者之間的關係。 more info >> |
|
|
诺泰与韩国领先医疗中心（峨山医疗中心）签署谅解备忘录 |
| 亚太地区专家合同研究组织诺泰今日宣布，其已经与韩国最大的医疗机构——峨山医疗中心（AMC）的临床研究中心签署了谅解备忘录（MOU）。该谅解备忘录正式确定了诺泰与国际领先医疗中心及其主要研究者之间的关系。 more info >> |
|
| Tuesday, April 18, 2017 |
|
|
노보테크, 韓 최대 의료기관 서울아산병원과 MoU 체결 |
| 아시아태평양 전문 임상시험수탁기관(CRO) 노보테크(Novotech)가 한국 최대 의료기관인 서울아산병원 임상시험센터와 MoU를 체결했다. 이로써 노보테크는 국제적으로 명망 높은 의료기관 및 그 산하의 핵심 연구소와 공식적인 파트너십을 맺게 됐다. more info >> |
|
|
Novotech signs MOU with South Korea's leading medical center, the Asan Medical Center |
| Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea's largest medical institution - The Asan Medical Center's (AMC) Clinical Trial Center. The MOU formalises Novotech's relationship with the internationally-leading medical center and its principal investigators. more info >> |
|
| Thursday, March 9, 2017 |
|
|
New Research reveals Asia poised as Preferred Destination for Clinical Trials |
| Frost & Sullivan released a white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific CRO Novotech presenting the findings to an audience of senior biotechnology and pharmaceutical executives in a private event at the Outsourcing in Clinical Trials - West Coast (OCT-WC 2017) conference, held Feb 22-23 in Burlingame, Ca. (USA). more info >> |
|
| Friday, March 3, 2017 |
|
|
Frost＆Sullivan的最新研究顯示亞洲是臨床試驗的首選地 |
Frost＆Sullivan今天發布了其與亞太專家CRO Novotech合作的最新白皮書“亞洲：臨床試驗的首選地”。新白皮書的研究表明，由於擁有大量無治療效果的患者庫，特殊的臨床基礎設施和人才，以及較低的運營成本，亞洲正迅速成為臨床研究的主力軍。
more info >> |
|
|
Frost＆Sullivan的最新研究显示亚洲是临床试验的首选地 |
Frost＆Sullivan今天发布了其与亚太专家CRO Novotech合作的最新白皮书“亚洲：临床试验的首选地”。新白皮书的研究表明，由于拥有大量无治疗效果的患者库，特殊的临床基础设施和人才，以及较低的运营成本，亚洲正迅速成为临床研究的主力军。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation
Mar 14, 2026 05:00 HKT/SGT
|
|
|
General MRO Aerospace 取得中國民航局認證，拓展全球維修能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace 获得中国民航局认证，拓展全球维护能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities
Mar 13, 2026 22:20 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00: JST
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT/SGT
|
|
|
CITIC Resources Deepens Dual-Engine Strategy of 'Investment + Trading', Continues to Promote High-Quality Development
Mar 13, 2026 21:01 HKT/SGT
|
|
|
中信資源深化「投資+貿易」雙輪戰略 持續驅動高質量發展 推進「上游資產布局、貿易業務拓展、生產運營提質」
Mar 13, 2026 20:53 HKT/SGT
|
|
|
中信资源深化「投资+贸易」双轮战略 持续驱动高质量发展 推进「上游资产布局、贸易业务拓展、生产运营提质」
Mar 13, 2026 20:40 HKT/SGT
|
|
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT/SGT
|
|
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 18:00: JST
|
|
|
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating "Online x Offline" O2O Community Finance Strategy
Mar 13, 2026 17:34 HKT/SGT
|
|
|
盈立證券一年拓展12個服務網點 全力深化「線上x線下」O2O社區金融佈局
Mar 13, 2026 17:21 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
